At two years after the end of the elective orthopedic surgery deferment related to the COVID-19 pandemic, there will be a cumulative backlog of more than 1 million surgical cases in an optimistic scenario.
While obesity remains a major concern in the United States of America, both surgical and pharmaceutical interventions have been underutilized, according to results intended to be presented at Digestive Disease Week 2020.
Nonsurgical options can be used to mitigate the harm from delaying surgery, including optimizing glycemic control in patients with type 2 diabetes and dietary or pharmacologic interventions for weight control.
Researchers concluded that bariatric surgery is strongly associated with an increased risk for colon cancer, though further research may be needed to establish an association between bariatric surgery and an increased risk for rectal cancer.
A Clinical Update review published in JAMA detailed current research surrounding the efficacy and safety of obesity treatment for adolescents, including behavioral interventions, pharmacotherapy, and bariatric surgery.